
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Mod... Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.3842 | -58.7731375249 | 0.6537 | 0.7262 | 0.2589 | 561604 | 0.61823778 | CS |
4 | -0.6702 | -71.320634245 | 0.9397 | 0.9588 | 0.2589 | 1082240 | 0.68271328 | CS |
12 | -0.7905 | -74.5754716981 | 1.06 | 1.1444 | 0.2589 | 569647 | 0.80569075 | CS |
26 | -1.5305 | -85.0277777778 | 1.8 | 3.6499 | 0.2589 | 3067950 | 1.56470486 | CS |
52 | -3.9605 | -93.6288416076 | 4.23 | 4.707 | 0.2589 | 1523908 | 1.57955765 | CS |
156 | -22.2305 | -98.8022222222 | 22.5 | 29.1 | 0.2589 | 596545 | 3.16449644 | CS |
260 | -14.7305 | -98.2033333333 | 15 | 131.7 | 0.2589 | 858304 | 22.34417989 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions